<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="43611" whole_study_id="24586" phs="001497" v="2" p="1" createDate="2021-08-20T08:55:07-05:00" completedByGPADate="2021-08-31T07:38:26-05:00" modDate="2021-09-22T22:24:52-05:00" maxParentChildStudyModDate="2021-09-22T22:24:52-05:00" handle="AdultGlioma" num_participants="2039"><StudyInfo accession="phs001497.v2.p1" parentAccession="phs001497.v2.p1"><BioProject id="PRJNA421232" entrez_id="421232" type="bp_admin_access"/><BioProject id="PRJNA421233" entrez_id="421233" type="bp_data_submission"/><StudyNameEntrez>The Adult Glioma Study</StudyNameEntrez><StudyTypes2 calculated="No"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="methylation_array"/><StudyType22 name="array_multi_sample_gen"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><Funding>R01 CA052689</Funding></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="WRENSCH" aid="2" auth="eRA" login="WRENSCH" fname="MARGARET" mname="" lname="WRENSCH" email="margaret.wrensch@ucsf.edu"><Role>PI</Role><Organization>UNIVERSITY OF CALIFORNIA, SAN FRANCISCO</Organization></Person><Person nedid="0011425634" aid="1" auth="cit" login="carrick" fname="Danielle" mname="Mercatante" lname="Carrick" email="carrick@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="LUCIEM" aid="2" auth="eRA" login="LUCIEM" fname="Lucie" mname="" lname="Mccoy" email="Lucie.McCoy@ucsf.edu"><Role>PI_ASSIST</Role><Organization>UNIVERSITY OF CALIFORNIA, SAN FRANCISCO</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001203526" aid="1" auth="cit" login="cagaananef" fname="Emilie" mname="Charlisse F" lname="Caga-Anan" email="charlisse.caga-anan@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>Work at University of California, San Francisco was supported by the National Institutes of Health (grant numbers R01CA52689, P50CA097257, R01CA126831, R01CA139020 and R25CA112355), as well as the Loglio Collective, the National Brain Tumor Foundation, the Stanley D. Lewis and Virginia S. Lewis Endowed Chair in Brain Tumor Research, the Robert Magnin Newman Endowed Chair in Neuro-oncology, and by donations from families and friends of John Berardi, Helen Glaser, Elvera Olsen, Raymond E. Cooper, and William Martinusen. This project was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant Number UL1 RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement # U58DP003862-01 awarded to the California Department of Public Health. The ideas and opinions expressed herein are those of the author(s) and endorsement by the State of California Department of Public Health, the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and Subcontractors is not intended nor should be inferred.

Subject recruitment methods for the Adult Glioma Study are outlined in detail in the following manuscript: Zhou M, Bracci PM, McCoy LS, Hsuang G, Wiemels JL, Rice T, Zheng S, Kelsey KT, Wrensch MR, Wiencke JK. Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time. Int J Cancer. 2015 Aug 15; 137(4): 826&#8211;836. PMCID: PMC4478165. Additional data from this study may be available by entering into a collaboration with the Adult Glioma Study.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access_timeout_extend" gsr_mode_label="Controlled-access (institution requested additional time)"/><ConsentGroup uid="2532" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

</Use-Restriction></ConsentGroup><ConsentGroup uid="2533" CGType="cg_class_DS" title="Disease-Specific (Brain tumors and all cancer, MDS)" name="DS-BT-CA-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Brain tumors and all cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="24586" whole_study_id="24586" phs="001497" v="1" p="1" createDate="2017-04-21T09:32:01-05:00" completedByGPADate="2017-04-25T15:36:35-05:00" modDate="2021-08-20T08:55:11-05:00" maxParentChildStudyModDate="2021-08-20T08:55:11-05:00" handle="AdultGlioma" num_participants="2039"><StudyInfo accession="phs001497.v1.p1" parentAccession="phs001497.v1.p1"><BioProject id="PRJNA421232" entrez_id="421232" type="bp_admin_access"/><BioProject id="PRJNA421233" entrez_id="421233" type="bp_data_submission"/><StudyNameEntrez>The Adult Glioma Study</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="methylation_array"/><StudyType22 name="array_multi_sample_gen"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>germline</StudyType><StudyType>dna</StudyType><StudyType>snp_array</StudyType><StudyType>methylation_array</StudyType><StudyType>array_derived_genotypes</StudyType><StudyType>array_derived_methylation</StudyType></StudyTypes><Funding>R01 CA052689</Funding></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="WRENSCH" aid="2" auth="eRA" login="WRENSCH" fname="MARGARET" mname="" lname="WRENSCH" email="margaret.wrensch@ucsf.edu"><Role>PI</Role><Organization>UNIVERSITY OF CALIFORNIA, SAN FRANCISCO</Organization></Person><Person nedid="0011425634" aid="1" auth="cit" login="carrick" fname="Danielle" mname="Mercatante" lname="Carrick" email="carrick@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="LUCIEM" aid="2" auth="eRA" login="LUCIEM" fname="Lucie" mname="" lname="Mccoy" email="Lucie.McCoy@ucsf.edu"><Role>PI_ASSIST</Role><Organization>UNIVERSITY OF CALIFORNIA, SAN FRANCISCO</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001203526" aid="1" auth="cit" login="cagaananef" fname="Emilie" mname="Charlisse F" lname="Caga-Anan" email="charlisse.caga-anan@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>Work at University of California, San Francisco was supported by the National Institutes of Health (grant numbers R01CA52689, P50CA097257, R01CA126831, R01CA139020 and R25CA112355), as well as the Loglio Collective, the National Brain Tumor Foundation, the Stanley D. Lewis and Virginia S. Lewis Endowed Chair in Brain Tumor Research, the Robert Magnin Newman Endowed Chair in Neuro-oncology, and by donations from families and friends of John Berardi, Helen Glaser, Elvera Olsen, Raymond E. Cooper, and William Martinusen. This project was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant Number UL1 RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement # U58DP003862-01 awarded to the California Department of Public Health. The ideas and opinions expressed herein are those of the author(s) and endorsement by the State of California Department of Public Health, the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and Subcontractors is not intended nor should be inferred.

Subject recruitment methods for the Adult Glioma Study are outlined in detail in the following manuscript: Zhou M, Bracci PM, McCoy LS, Hsuang G, Wiemels JL, Rice T, Zheng S, Kelsey KT, Wrensch MR, Wiencke JK. Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time. Int J Cancer. 2015 Aug 15; 137(4): 826&#8211;836. PMCID: PMC4478165. Additional data from this study may be available by entering into a collaboration with the Adult Glioma Study.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access_timeout_extend" gsr_mode_label="Controlled-access (institution requested additional time)"/><ConsentGroup uid="2532" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

</Use-Restriction></ConsentGroup><ConsentGroup uid="2533" CGType="cg_class_DS" title="Disease-Specific (Brain tumors and all cancer, MDS)" name="DS-BT-CA-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Brain tumors and all cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>